Although preliminary and with some limitation due to the small sample of transgenic mice tested here, these results are encouraging and the approach deserves further studies for the development of anti-Tat Ab-based therapies for AIDS-KS, a tumor that despite recent improvements continues to be an incurable disease also on the cART era [2]. This evidence concerns the gene TAT and neoplasm.